Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ornstein

Showing results (81-90 of 1,068) with videos related to

Pageof 107
Sort By:
Archives of Pathology & Laboratory Medicine|December 1, 2017
Factor V Inhibitors: A Diagnostic and Therapeutic ChallengeNicholas J Olson, Deborah L Ornstein
Expert Review of Anticancer Therapy|May 5, 2016
The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinomaMoshe C Ornstein, Brian I Rini
Paediatrics & Child Health|July 15, 2021
10 years later: revisiting the patchwork quilt of child protection in CanadaCourtney Gullickson, Emma Bartlett, Amy Ornstein
Journal of Autism and Developmental Disorders|February 2, 2008
Parenting stress in mothers and fathers of toddlers with autism spectrum disorders: associations with child characteristicsNaomi Ornstein Davis, Alice S Carter
The Journal of Ambulatory Care Management|March 6, 2014
Quality indicators for primary care: an example for chronic kidney diseaseCara B Litvin, Steven M Ornstein
The Journal of Cardiovascular Surgery|September 1, 1979
An unusual late complication of superior mesenteric embolectomyR G Hughes, M H Ornstein
Advances in Child Development and Behavior|January 1, 1985
Effects of the knowledge base on children's memory strategiesP A Ornstein, M J Naus
Social Science & Medicine (1982)|February 12, 2026
Family structure, "Kinlessness", and cognitive decline: Social connectedness and contextual variation in EuropeChristine A Mair, Katherine A Ornstein
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 9, 2012
Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorderNaomi Ornstein Davis, Scott H Kollins
JCO Oncology Practice|February 12, 2020
Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study ApproachLaura S Wood, Moshe C Ornstein
Pageof 107

Showing results (81-90 of 1,068) with videos related to

Sort By:
Pageof 107
Archives of Pathology & Laboratory Medicine|December 1, 2017
Factor V Inhibitors: A Diagnostic and Therapeutic ChallengeNicholas J Olson, Deborah L Ornstein
Expert Review of Anticancer Therapy|May 5, 2016
The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinomaMoshe C Ornstein, Brian I Rini
Paediatrics & Child Health|July 15, 2021
10 years later: revisiting the patchwork quilt of child protection in CanadaCourtney Gullickson, Emma Bartlett, Amy Ornstein
Journal of Autism and Developmental Disorders|February 2, 2008
Parenting stress in mothers and fathers of toddlers with autism spectrum disorders: associations with child characteristicsNaomi Ornstein Davis, Alice S Carter
The Journal of Ambulatory Care Management|March 6, 2014
Quality indicators for primary care: an example for chronic kidney diseaseCara B Litvin, Steven M Ornstein
The Journal of Cardiovascular Surgery|September 1, 1979
An unusual late complication of superior mesenteric embolectomyR G Hughes, M H Ornstein
Advances in Child Development and Behavior|January 1, 1985
Effects of the knowledge base on children's memory strategiesP A Ornstein, M J Naus
Social Science & Medicine (1982)|February 12, 2026
Family structure, "Kinlessness", and cognitive decline: Social connectedness and contextual variation in EuropeChristine A Mair, Katherine A Ornstein
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 9, 2012
Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorderNaomi Ornstein Davis, Scott H Kollins
JCO Oncology Practice|February 12, 2020
Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study ApproachLaura S Wood, Moshe C Ornstein
Pageof 107